_scan_pd.jpg)
For the financial third quarter of 2022 company Deficit has widen of $-8.04 per share compare to $0.00 a year ago and EPS improved from $-11.97 per share from the previous financial reporting period.
Revenues remained unaffected to $
0.00 millions from $0.46 millions in the corresponding financial reporting period a year ago and sequentially from $0.07 millions.
For the financial third quarter of 2022 H Cyte Inc realized net loss of $-2.279 million, bigger than $-0.587 million a year ago.